In vivo protection against gamma-irradiation with 5-androstenediol.
Whitnall
M H
MH
Radiation Casualty Management Team, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889-5603, USA.
Elliott
T B
TB
Landauer
M R
MR
Jackson
W E
WE
Wilhelmsen
C L
CL
Mckinney
L
L
Kumar
K S
KS
Srinivasan
V
V
Ledney
G D
GD
Seed
T M
TM
D015114:Androstenediol / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D005260:Female; D005720:Gamma Rays / Q000009:adverse effects; D007694:Killer Cells, Natural; D007958:Leukocyte Count; D008297:Male; D051379:Mice; D009000:Monocytes; D009503:Neutropenia / Q000209:etiology / Q000517:prevention & control; D011832:Radiation Injuries / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000209:etiology / Q000517:prevention & control; D014916:Whole-Body Irradiation
D011837:Radiation-Protective Agents; D015114:Androstenediol